DENTSPLY SIRONA Inc. (NASDAQ:XRAY) Shares Purchased by Comerica Bank

Comerica Bank lifted its position in shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY - Free Report) by 41.2% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 225,080 shares of the medical instruments supplier's stock after buying an additional 65,709 shares during the quarter. Comerica Bank owned approximately 0.11% of DENTSPLY SIRONA worth $4,272,000 at the end of the most recent quarter.

Several other hedge funds have also modified their holdings of the stock. Vanguard Group Inc. grew its holdings in DENTSPLY SIRONA by 0.3% in the fourth quarter. Vanguard Group Inc. now owns 20,183,260 shares of the medical instruments supplier's stock valued at $383,078,000 after purchasing an additional 65,478 shares during the period. First Eagle Investment Management LLC grew its holdings in DENTSPLY SIRONA by 2.5% in the fourth quarter. First Eagle Investment Management LLC now owns 14,500,409 shares of the medical instruments supplier's stock valued at $275,218,000 after purchasing an additional 348,532 shares during the period. Nuance Investments LLC grew its holdings in DENTSPLY SIRONA by 25.0% in the fourth quarter. Nuance Investments LLC now owns 13,545,981 shares of the medical instruments supplier's stock valued at $257,103,000 after purchasing an additional 2,708,097 shares during the period. Price T Rowe Associates Inc. MD grew its holdings in DENTSPLY SIRONA by 18.7% in the fourth quarter. Price T Rowe Associates Inc. MD now owns 12,549,242 shares of the medical instruments supplier's stock valued at $238,186,000 after purchasing an additional 1,975,404 shares during the period. Finally, Fuller & Thaler Asset Management Inc. grew its holdings in DENTSPLY SIRONA by 2.8% in the fourth quarter. Fuller & Thaler Asset Management Inc. now owns 11,539,418 shares of the medical instruments supplier's stock valued at $219,018,000 after purchasing an additional 314,343 shares during the period. 95.70% of the stock is owned by institutional investors and hedge funds.

Analyst Ratings Changes

A number of equities research analysts recently issued reports on the stock. Needham & Company LLC restated a "hold" rating on shares of DENTSPLY SIRONA in a report on Thursday, March 13th. Barrington Research lowered their target price on shares of DENTSPLY SIRONA from $24.00 to $20.00 and set an "outperform" rating for the company in a report on Friday, February 28th. UBS Group reduced their price target on shares of DENTSPLY SIRONA from $27.00 to $25.00 and set a "buy" rating on the stock in a research report on Friday. Robert W. Baird reduced their price target on shares of DENTSPLY SIRONA from $22.00 to $20.00 and set a "neutral" rating on the stock in a research report on Friday, February 28th. Finally, Jefferies Financial Group cut shares of DENTSPLY SIRONA from a "buy" rating to a "hold" rating and reduced their price target for the company from $30.00 to $20.00 in a research report on Thursday, January 23rd. Eleven equities research analysts have rated the stock with a hold rating and three have issued a buy rating to the stock. According to data from MarketBeat, DENTSPLY SIRONA currently has a consensus rating of "Hold" and a consensus price target of $20.27.

DENTSPLY SIRONA Stock Down 0.6%

Shares of XRAY stock traded down $0.10 on Friday, hitting $15.81. The stock had a trading volume of 4,397,789 shares, compared to its average volume of 2,959,440. The firm has a market capitalization of $3.15 billion, a price-to-earnings ratio of -7.64, a P/E/G ratio of 1.80 and a beta of 0.92. The stock's 50 day moving average is $14.36 and its 200-day moving average is $17.54. The company has a debt-to-equity ratio of 0.72, a quick ratio of 0.84 and a current ratio of 1.25. DENTSPLY SIRONA Inc. has a 52-week low of $12.16 and a 52-week high of $28.69.

DENTSPLY SIRONA (NASDAQ:XRAY - Get Free Report) last announced its earnings results on Thursday, May 8th. The medical instruments supplier reported $0.43 earnings per share for the quarter, beating the consensus estimate of $0.29 by $0.14. The business had revenue of $879.00 million during the quarter, compared to the consensus estimate of $854.75 million. DENTSPLY SIRONA had a negative net margin of 10.59% and a positive return on equity of 12.62%. The business's quarterly revenue was down 7.8% compared to the same quarter last year. During the same period in the prior year, the firm earned $0.42 earnings per share. As a group, research analysts expect that DENTSPLY SIRONA Inc. will post 1.84 earnings per share for the current year.

DENTSPLY SIRONA Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Friday, April 11th. Stockholders of record on Friday, March 28th were paid a $0.16 dividend. The ex-dividend date of this dividend was Friday, March 28th. This represents a $0.64 annualized dividend and a dividend yield of 4.05%. DENTSPLY SIRONA's dividend payout ratio (DPR) is presently -14.10%.

Insider Activity

In related news, Director Gregory T. Lucier purchased 15,142 shares of the business's stock in a transaction that occurred on Monday, March 3rd. The shares were purchased at an average cost of $16.51 per share, with a total value of $249,994.42. Following the completion of the acquisition, the director now directly owns 81,971 shares of the company's stock, valued at approximately $1,353,341.21. The trade was a 22.66% increase in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Insiders own 0.50% of the company's stock.

About DENTSPLY SIRONA

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.